Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) and the Brussels-based Oncidium foundation today announce that results for the NOBLE Registry of TLX599-CDx (99m Tc-iPSMA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback